Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MRK [NYSE]
Merck & Co. Inc.
IndexDJIA S&P500 P/E31.14 EPS (ttm)1.90 Insider Own0.03% Shs Outstand2.88B Perf Week0.96%
Market Cap170.68B Forward P/E16.40 EPS next Y3.61 Insider Trans25.90% Shs Float2.87B Perf Month1.65%
Income5.61B PEG7.74 EPS next Q0.88 Inst Own75.80% Short Float1.17% Perf Quarter4.95%
Sales43.55B P/S3.92 EPS this Y-26.50% Inst Trans-1.18% Short Ratio4.09 Perf Half Y6.94%
Book/sh16.58 P/B3.57 EPS next Y3.41% ROA5.40% Target Price61.67 Perf Year27.96%
Cash/sh4.64 P/C12.74 EPS next 5Y4.03% ROE11.50% 52W Range43.54 - 59.66 Perf YTD20.04%
Dividend1.76 P/FCF32.75 EPS past 5Y-16.50% ROI6.60% 52W High-0.82% Beta0.39
Dividend %2.97% Quick Ratio1.50 Sales past 5Y13.00% Gross Margin59.80% 52W Low35.88% ATR0.79
Employees77300 Current Ratio1.90 Sales Q/Q-0.70% Oper. Margin17.90% RSI (14)59.05 Volatility1.19% 1.43%
OptionableYes Debt/Eq0.48 EPS Q/Q126.70% Profit Margin12.90% Rel Volume0.63 Prev Close58.85
ShortableYes LT Debt/Eq0.38 EarningsJul 29 BMO Payout90.60% Avg Volume8.19M Price59.17
Recom2.40 SMA202.71% SMA501.96% SMA2009.11% Volume5,187,561 Change0.54%
30-Apr-14Reiterated Argus Buy $62 → $66
11-Apr-14Reiterated MKM Partners Buy $64 → $70
05-Feb-14Reiterated Argus Buy $54 → $62
14-Jan-14Reiterated MKM Partners Buy $59 → $64
03-Jun-13Reiterated MKM Partners Buy $54 → $59
15-Apr-13Reiterated Barclays Overweight $45 → $60
04-Feb-13Reiterated MKM Partners Buy $51 → $52
04-Feb-13Reiterated Barclays Overweight $46 → $45
20-Nov-12Upgrade MKM Partners Neutral → Buy $47 → $51
17-Oct-12Reiterated MP Advisors Outperform $45 → $50
30-Jul-12Reiterated UBS Buy $45 → $50
13-Jul-12Upgrade MP Advisors Market Perform → Outperform $45
03-Feb-12Reiterated Barclays Capital Overweight $38 → $40
03-Feb-12Downgrade MKM Partners Buy → Neutral $42 → $40
29-Nov-11Initiated MKM Partners Buy $38
14-Sep-11Reiterated Barclays Capital Overweight $41 → $38
16-May-11Reiterated UBS Buy $40 → $42
04-Feb-11Reiterated UBS Buy $42 → $40
24-Jan-11Reiterated Deutsche Bank Buy $48 → $43
24-Jan-11Reiterated Barclays Capital Overweight $43 → $41
22-Aug-14 09:00AM  Heart Doctor Pay Drops To $558K As Interventions Scrutinized at Forbes
20-Aug-14 01:03PM  3 Drugs Stocks On The Rise at TheStreet
19-Aug-14 06:27PM  This stock may be hazardous to your financial health Talking Numbers
18-Aug-14 03:45PM  Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data Zacks
08:13AM  Washington Post Off Base In Critiquing Pharma Efforts In Ebola at Forbes
15-Aug-14 06:10PM  Biotech Leader Gilead Sciences Scores Sovaldi Win at Investor's Business Daily
05:44PM  Gilead Wins Sovaldi Dispute With Roche, U.K. Nod at Investor's Business Daily
01:04PM  MERCK & CO. INC. Financials EDGAR Online Financials
10:13AM  Digital Transformation Moves Pharma "Beyond the Pill" at Forbes
09:00AM  Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal PR Newswire
08:00AM  Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed Zacks
01:57AM  Forget Inversions, These 20 Huge, Profitable Companies Already Pay Zero Tax at Forbes
14-Aug-14 04:00PM  Merck's Insomnia Drug Belsomra Approved by the FDA Zacks
02:57PM  [video] Pfizer and Merck Receive Key Regulatory Approvals at TheStreet
02:42PM  US STOCKS-Wall St rises after Putin comments ease Ukraine worries Reuters
10:09AM  US STOCKS-Wall St edges up after Putin comments, Cisco falls Reuters
09:00AM  Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals PR Newswire
08:25AM  Why Pfizer (PFE) Stock Is Up Today at TheStreet
07:31AM  US STOCKS-Futures tick up ahead of jobless claims data Reuters
07:00AM  Must-See Charts: 5 Big Stocks to Trade for Gains at TheStreet
13-Aug-14 08:59PM  The F.D.A. Approves a Pill to Help People Stay Asleep at New York Times
08:59PM  The F.D.A. Approves a Pill to Help People Stay Asleep at New York Times
05:58PM  Merck Statement regarding Role of PNEUMOVAX┬« 23 (Pneumococcal Vaccine Polyvalent) in Updated ACIP Recommendations for Pneumococcal Vaccination in Adults Business Wire
04:49PM  FDA Approves BELSOMRA┬« (suvorexant) for the Treatment of Insomnia Business Wire
04:39PM  FDA approves new sleeping drug from Merck AP
04:30PM  Stocks close higher for the third time in four days on tech boost at CNBC
03:46PM  U.S. FDA approves Merck insomnia drug Reuters
03:41PM  Merck Wins U.S. Approval of New Type of Sleeping Pill at Bloomberg
02:29PM  Stocks higher on biotech, transports at CNBC
01:49PM  Stocks higher on biotech, transports; Nasdaq up 1% at CNBC
01:13PM  20 U.S. companies that paid 0% in taxes Yahoo Finance
12:46PM  Stocks higher on biotech, transports at CNBC
11:59AM  Stocks rise, all S&P sectors gain on easing geopolitics at CNBC
11:40AM  [video] Investors should expect more from Merck: Pro at CNBC
11:28AM  Stocks rise, all S&P sectors gain on easing geopolitics at CNBC
10:25AM  Stocks hold gains; business inventories up, geopolitics in backseat at CNBC
08:59AM  [$$] Germany's Merck Still Lacks Direction at The Wall Street Journal
01:57AM  [$$] Merck KGaA Net Profit Falls at The Wall Street Journal
01:16AM  Merck KGaA Profit Rises as AZ Acquisition Offsets Euro at Bloomberg
12:34AM  Europe set to open mixed; BoE report ahead at CNBC
12-Aug-14 10:48AM  Intercept Pharma Soars On Liver-Disease Drug Data at Investor's Business Daily
09:46AM  Unlocking the Mystery; Why US 10 Year Treasury Yields are Down at 2.4%, Ten Things You Need to Know at Forbes
09:28AM  [video] Cramer's Mad Dash: Intercept soars at CNBC
11-Aug-14 12:45PM  Merck KGaA is Fined by Brazil for Conspiring to Thwart Generic Drugs at The Wall Street Journal
08-Aug-14 01:03PM  Drugs Stocks On The Rise With Help From 3 Stocks at TheStreet
07-Aug-14 05:04PM  MERCK & CO. INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
06:51AM  [video] Clearing FDA hurdles at CNBC
06:45AM  SNB Trims Holdings in Apple, Exxon, J&J, SEC Filing Shows at Bloomberg
06-Aug-14 06:00AM  The R&D Hall of Fame: Who makes the cut? at CNBC
06:00AM  The R&D Hall of Fame: Which companies got elected? at CNBC
05-Aug-14 01:00PM  Merck Publishes 2013 Global Corporate Responsibility Report Business Wire
07:33AM  Saving kids: When unapproved drugs are the only hope at CNBC
06:00AM  Merck Completes Tender Offer to Acquire Idenix Business Wire
04-Aug-14 01:10PM  [video] Pros share top value plays at CNBC
31-Jul-14 03:30PM  3 Reasons To Buy Merck For The Long Term Benzinga
02:12PM  Len Schleifer's Science Focus Pays Off At Regeneron at Investor's Business Daily
30-Jul-14 07:01PM  Merck, J&J, Baxter Provide Healthy Dividend Stream at Investor's Business Daily
04:07PM  Stocks mixed; Fed tapers and GDP better than forecast at CNBC
03:48PM  US stocks mixed after Fed retains dovish stance at CNBC
03:07PM  Second Quarter Results Show Earnings And Revenue Growth at Forbes
02:56PM  US stocks mixed after Fed retains dovish stance at CNBC
02:36PM  Stocks mostly higher as Fed retains dovish stance at CNBC
02:07PM  S&P 500 turns positive as stocks cut losses after FOMC at CNBC
11:53AM  Stocks mostly drop; upbeat GDP fuels rate-hike talk at CNBC
10:26AM  Hospira Beats on Earnings and Sales in Q2, Boosts Guidance Zacks
09:23AM  Pharma ETFs in Focus on String of Earnings Beat Zacks
29-Jul-14 07:15PM  Stocks close lower as global tensions take a toll at USA TODAY
05:46PM  Stocks close lower as global tensions take a toll at USA TODAY
05:37PM  Stocks close lower as global tensions take a toll at USA TODAY
05:32PM  Merck, Pfizer Ramping R&D After Q2 Earnings Beat at Investor's Business Daily
04:24PM  Stocks close lower as global tensions take a toll at USA TODAY
04:03PM  Stocks close lower as global tensions take a toll at USA TODAY
03:57PM  Path for Skirting U.S. Taxes Widens With REIT Blueprint Bloomberg
03:50PM  Stocks mixed as Dow slides further from 17,000 at USA TODAY
03:49PM  Pharmaceutical ETFs Are Health Care Sector Standouts Benzinga
03:46PM  Pfizer Traders Fickle on Stock After Q2 Beat StockTwits
02:50PM  US STOCKS-Wall St edges lower on UPS outlook, telecom shares rally Reuters
02:33PM  Stocks mixed as Dow fights for 17,000 at USA TODAY
02:23PM  US stocks struggle ahead of Fed decision at Financial Times
02:16PM  Stocks inch up ahead of economic data AP
02:15PM  [video] Pfizer and Merck Top Quarterly Earnings Expectations, Shares Rise at TheStreet
01:28PM  Stocks slightly higher as Dow fights for 17,000 at USA TODAY
01:02PM  3 Stocks Boosting The Drugs Industry Higher at TheStreet
01:00PM  Treasury prices steady after 5-year notes auction at CNBC
12:46PM  Merck Pops On Good Profits, Tax Deal? at Barrons.com
12:34PM  Stocks turn mixed ahead of economic data AP
12:28PM  Treasurys mostly flat ahead of 5-year note auction at CNBC
12:27PM  Merck (MRK) On Momo Momentum Watch Today at TheStreet
12:25PM  US STOCKS-Wall St flat as telecom gains offset by earnings Reuters
12:09PM  [video] Pfizer CEO to CNBC: Tax reform would bring jobs back to US at CNBC
12:08PM  [video] U.S. Stocks Mixed on Geopolitical Worries Despite Upbeat Consumer at TheStreet
12:05PM  Stocks give back gains on rising global fears at USA TODAY
11:50AM  Stocks turn flat at midday ahead of economic data AP
11:45AM  Merck 2Q profit more than doubles AP
11:30AM  Stocks mixed as earnings compete with global worries at USA TODAY
11:30AM  Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts Zacks
11:29AM  [video] Stocks Start Higher as Investors React Positively to Earnings at TheStreet
11:23AM  Merck, Pfizer Beat Q2 Earnings Estimates at Investor's Business Daily
11:21AM  Merck: No Tax Inversions, Just Bolt-on M&A at The Wall Street Journal
11:16AM  US STOCKS-Wall St gains, telecoms sector lifted by Windstream Reuters
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company's Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, immunology, infectious diseases, and others. This segment also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. The company's Consumer Care segment develops, manufactures, and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant sprays; and products for occasional constipation, frequent heartburn, and overactive bladder in women; foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has collaborations with AstraZeneca LP, Pfizer Inc., Samsung Bioepis Co., Ltd., Sanofi Pasteur S.A., and Sysmex Inostics GmbH. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRAZIER KENNETH CChairman, President & CEOAug 11Option Exercise34.2012,875440,272345,562Aug 12 09:01 AM
FRAZIER KENNETH CChairman, President & CEOAug 11Sale57.0010,058573,306335,504Aug 12 09:01 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Option Exercise45.3823,4001,061,82042,844Aug 05 09:56 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Sale56.6428,6691,623,72014,175Aug 05 09:56 AM
REPRESAS CARLOS EDirectorAug 01Option Exercise35.195,000175,9505,500Aug 05 10:16 AM
FRAZIER KENNETH CChairman, President & CEOJul 10Option Exercise34.2012,876440,307351,474Jul 10 03:47 PM
FRAZIER KENNETH CChairman, President & CEOJul 10Sale58.039,987579,545341,487Jul 10 03:47 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Option Exercise30.01180,0475,403,278273,611Jul 08 02:16 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Sale59.16180,04710,650,93293,564Jul 08 02:16 PM
Deese Willie AExe V-P & Pres. MMDJun 27Option Exercise27.8572,2902,013,164178,512Jun 30 04:23 PM
Deese Willie AExe V-P & Pres. MMDJun 27Sale58.2672,2904,211,254106,222Jun 30 04:23 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 14Sale55.9110,527588,5840May 14 02:48 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Option Exercise34.2012,876440,307345,927May 13 03:56 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Sale55.0010,220562,100335,707May 13 03:56 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 04Option Exercise0.0019,147019,147May 06 04:03 PM
Golestani ClarkEVP & Chief Info OfficerMay 04Option Exercise0.002,05109,278May 06 04:02 PM
GRADDICK WEIR MIRIAN MExe V-P, HRMay 04Option Exercise0.009,300098,387May 06 04:02 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareMay 04Option Exercise0.005,470038,311May 06 04:02 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.004,240011,999May 06 04:02 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Option Exercise0.009,8470132,660May 06 04:02 PM
Rosenblatt MichaelExec V-P & Chief Med OfficerMay 04Option Exercise0.004,103026,720May 06 04:02 PM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerMay 04Option Exercise0.004,103020,828May 06 04:01 PM
Deese Willie AExe V-P & Pres. MMDMay 04Option Exercise0.007,6590109,671May 06 04:01 PM
FRAZIER KENNETH CChairman, President & CEOMay 04Option Exercise0.0041,0280351,522May 06 04:01 PM
HARRISON WILLIAM B JRDirectorApr 25Option Exercise47.235,000236,1506,400Apr 29 11:36 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Option Exercise34.2012,876440,307320,541Apr 11 09:53 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Sale57.2410,047575,108310,494Apr 11 09:53 AM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Option Exercise39.90145,2255,794,929267,070Apr 04 05:07 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Sale56.43145,2258,195,164121,845Apr 04 05:07 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Option Exercise48.246,375307,53012,036Feb 14 05:11 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Sale55.475,990332,2766,046Feb 14 05:11 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Option Exercise36.5649,7501,818,86071,457Feb 14 11:17 AM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Sale55.0443,8702,414,57027,587Feb 14 11:17 AM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Option Exercise47.6518,000857,70518,000Feb 13 10:12 AM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Option Exercise48.2410,000482,40020,697Feb 11 05:07 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Option Exercise48.2445,0002,170,800304,349Feb 11 05:34 PM
FRAZIER KENNETH CChairman, President & CEOFeb 11Sale54.5241,5202,263,683262,829Feb 11 05:34 PM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Sale55.7010,000557,00210,697Feb 11 05:07 PM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Sale55.6118,0001,000,9350Feb 13 10:12 AM
WEEKS WENDELL PDirectorFeb 10Option Exercise47.235,000236,1505,100Feb 11 03:41 PM
WENDELL PETER CDirectorFeb 10Option Exercise47.235,000236,1506,000Feb 11 03:48 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Option Exercise48.2420,000964,800156,049Feb 11 03:54 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Sale54.6850,0002,734,155106,049Feb 11 03:54 PM
WENDELL PETER CDirectorFeb 10Sale54.445,000272,1931,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Sale54.265,000271,283100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDJan 27Option Exercise47.7930,0001,433,700136,049Jan 28 10:09 AM